In vitro activities of antifungal drugs against Rhinocladiella mackenziei, an agent of fatal brain infection

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 1, 2009, Pages 175-177

  Badali, Hamid ^a,b,c   de Hoog, G Sybren ^a,b   Curfs Breuker, Ilse ^d   Meis, Jacques F ^d  

^a CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

Cerebral fungal infection; In vitro susceptibility; Isavuconazole; Posaconazole; Ramichloridium

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ISAVUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; POSACONAZOLE; VORICONAZOLE; ANTIFUNGAL AGENT;

ADULT; AGED; ANTIFUNGAL SUSCEPTIBILITY; BRAIN ABSCESS; BRAIN INFECTION; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CONTROLLED STUDY; FEMALE; FUNGUS; HUMAN; IN VITRO STUDY; LETTER; LIVER ABSCESS; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PAECILOMYCES; PAECILOMYCES VARIOTII; RHINOCLADIELLA MACKENZIEI; ASCOMYCETES; BRAIN; CENTRAL NERVOUS SYSTEM INFECTION; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MYCOSIS;

AGED; ANTIFUNGAL AGENTS; ASCOMYCOTA; BRAIN; CENTRAL NERVOUS SYSTEM INFECTIONS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOSES;

EID: 77950363942     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp390     Document Type: Letter

References (8)

1. Li DM, de Hoog GS. Cerebral phaeohyphomycosis-a cure at what lengths? Lancet Infect Dis 2009; 9: 376-83.
2. Kantarcioglu AS, de Hoog GS. Infections of the central nervous system by melanized fungi: a review of cases presented between 1999 and 2004. Mycoses 2004; 47: 4-13.
3. Al-Abdely HM, Najvar L, Bocanegra R et al. SCH 56592, amphotericin B, or itraconazole therapy of experimental murine cerebral phaeo-hyphomycosis due to Ramichloridium obovoideum ("R. mackenziei"). Antimicrob Agents Chemother 2000; 44: 1159-62.
4. Sutton DA, Slifkin M, Yakulis R et al. US case report of cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (R. mackenziei): criteria for identification, therapy, and review of other known dematiaceous neurotropic taxa. J Clin Microbiol 1998; 36: 708-15.
5. Al-Abdely HM, Alkhunaizi AM, Al-Tawfiq JA et al. Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole. Med Mycol 2005; 43:91-5.
6. Clinical Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi-Second Edition: Approved Standard M38-A2 CLSI, Wayne, PA, USA, 2008.
7. Ruping MJGT, Albermannn N, Ebinger F et al. Posaconazole concentrations in the central nervous system. J Antimicrob Chemother 2008; 62: 1468-70.
8. Odabasi Z, Paetznick VL, Rodiguez JR et al. In vitro activity of anidulafungin against selected clinically important mold isolates. Antimicrob Agents Chemother 2004; 48: 1912-5.